A Nutritional Strategy to Improve Oxygenation and Decrease Morbidity in Patients Who Have Acute Respiratory Distress Syndrome

Respiratory Care Clinics of North America

Volumn 12, Issue 4, 2006, Pages 547-566

  DeMichele, Stephen J ^a   Wood, Steven M ^a   Wennberg, Ann K ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; ARACHIDONIC ACID; CARBON DIOXIDE; CORTICOSTEROID; GAMMA LINOLENIC ACID; ICOSAPENTAENOIC ACID; INTERLEUKIN 6; INTERLEUKIN 8; LINOLEIC ACID; LINOLEOYL COENZYME A DESATURASE; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; TUMOR NECROSIS FACTOR; VASODILATOR AGENT;

ADULT RESPIRATORY DISTRESS SYNDROME; ANTIINFLAMMATORY ACTIVITY; ARTIFICIAL VENTILATION; CLINICAL TRIAL; CYTOKINE PRODUCTION; ENTERIC FEEDING; HUMAN; INCIDENCE; INFLAMMATION; INTENSIVE CARE; LIPID DIET; LOW FAT DIET; MORBIDITY; NEUTROPHIL COUNT; NONHUMAN; NUTRITIONAL SUPPORT; OXYGENATION; PATIENT CARE; REVIEW; SAFETY;

ANIMALS; CLINICAL TRIALS; ENTERAL NUTRITION; FATTY ACIDS, UNSATURATED; GAMMA-LINOLENIC ACID; HUMANS; MORBIDITY; OXYGEN; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 37849185691     PISSN: 10785337     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rcc.2006.09.006     Document Type: Review

References (59)

1. Rubenfeld G.D., Caldwell E., Peabody E., et al. Incidence and outcomes of acute lung injury. N Engl J Med 353 (2005) 1685-1693
2. Mutlu G.M., and Budinger G.R. Incidence and outcomes of acute lung injury. N Engl J Med 354 (2006) 416-417
3. Weinacker A.B., and Vaszar L.T. Acute respiratory distress syndrome: physiology and new management strategies. Annu Rev Med 52 (2001) 221-237
4. Brigham K.L., Bowers R., and Haynes J. Increased sheep lung vascular permeability caused by Escherichia coli endotoxin. Circ Res 45 (1979) 292-297
5. Fein A., Grossman R.F., Jones J.G., et al. The value of edema fluid protein measurement in patients with pulmonary edema. Am J Med 67 (1979) 32-38
6. Brigham K.L. Mechanisms of lung injury. Clin Chest Med 3 (1982) 9-24
7. Baldwin S.R., Simon R.H., Grum C.M., et al. Oxidant activity in expired breath of patients with adult respiratory distress syndrome. Lancet 1 (1986) 11-14
8. Gadek J.E. Adverse effects of neutrophils on the lung. Am J Med 92 (1992) 27S-31S
9. Rivkind A.I., Siegel J.H., Littleton M., et al. Neutrophil oxidative burst activation and the pattern of respiratory physiologic abnormalities in the fulminant post-traumatic adult respiratory distress syndrome. Circ Shock 33 (1991) 48-62
10. Ware L.B., and Matthay M.A. The acute respiratory distress syndrome. N Engl J Med 342 (2000) 1334-1349
11. Bernard G.R., Artigas A., Brigham K.L., et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149 (1994) 818-824
12. Parsons P.E., Eisner M.D., Thompson B.T., et al. Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit Care Med 33 (2005) 1-6
13. Brigham K.L. Metabolites of arachidonic acid in experimental lung vascular injury. Fed Proc 44 (1985) 43-45
14. Henderson Jr. W.R. Lipid-derived and other chemical mediators of inflammation in the lung. J Allergy Clin Immunol 79 (1987) 543-553
15. Bone R.C. Treatment of adult respiratory distress syndrome with diuretics, dialysis, and positive end-expiratory pressure. Crit Care Med 6 (1978) 136-139
16. Simmons R.S., Berdine G.G., Seidenfeld J.J., et al. Fluid balance and the adult respiratory distress syndrome. Am Rev Respir Dis 135 (1987) 924-929
17. Brower R.G., Ware L.B., Berthiaume Y., et al. Treatment of ARDS. Chest 120 (2001) 1347-1367
18. Rosenberg A.L. Fluid management in patients with acute respiratory distress syndrome. Respir Care Clin N Am 9 (2003) 481-493
19. Bernard G.R. Acute respiratory distress syndrome: a historical perspective. Am J Respir Crit Care Med 172 (2005) 798-806
20. Mizock B.A. Nutritional support in acute lung injury and acute respiratory distress syndrome. Nutr Clin Pract 16 (2001) 319-328
21. Mizock B.A., and DeMichele S.J. The acute respiratory distress syndrome: role of nutritional modulation of inflammation through dietary lipids. Nutr Clin Pract 19 (2004) 563-574
22. Harper H.A., Rodwell V.W., and Mayes P.A. Review of physiological chemistry (1979), Lang Medical Publications, Los Altos (CA)
23. 2 and reduces the period of ventilation in artificially ventilated patients. Intensive Care Med 15 (1989) 290-295
24. Talpers S.S., Romberger D.J., Bunce S.B., et al. Nutritionally associated increased carbon dioxide production. Excess total calories vs high proportion of carbohydrate calories. Chest 102 (1992) 551-555
25. Simopoulos A.P. Evolutionary aspects of omega-3 fatty acids in the food supply. Prostaglandins Leukot Essent Fatty Acids 60 (1999) 421-429
26. Simopoulos A.P. n-3 fatty acids and human health: defining strategies for public policy. Lipids 36 Suppl (2001) S83-S89
27. Geerling B.J., Badart-Smook A., van Deursen C., et al. Nutritional supplementation with N-3 fatty acids and antioxidants in patients with Crohn's disease in remission: effects on antioxidant status and fatty acid profile. Inflamm Bowel Dis 6 (2000) 77-84
28. Nielsen A.A., Jorgensen L.G., Nielsen J.N., et al. Omega-3 fatty acids inhibit an increase of proinflammatory cytokines in patients with active Crohn's disease compared with omega-6 fatty acids. Aliment Pharmacol Ther 22 (2005) 1121-1128
29. Simopoulos A.P. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr 21 (2002) 495-505
30. Bjorkkjaer T., Brunborg L.A., Arslan G., et al. Reduced joint pain after short-term duodenal administration of seal oil in patients with inflammatory bowel disease: comparison with soy oil. Scand J Gastroenterol 39 (2004) 1088-1094
31. Seidner D.L., Lashner B.A., Brzezinski A., et al. An oral supplement enriched with fish oil, soluble fiber, and antioxidants for corticosteroid sparing in ulcerative colitis: a randomized, controlled trial. Clin Gastroenterol Hepatol 3 (2005) 358-369
32. Grimm H., Mayer K., Mayser P., et al. Regulatory potential of n-3 fatty acids in immunological and inflammatory processes. Br J Nutr 87 Suppl 1 (2002) S59-S67
33. von Schacky C., Baumann K., and Angerer P. The effect of n-3 fatty acids on coronary atherosclerosis: results from SCIMO, an angiographic study, background and implications. Lipids 36 Suppl (2001) S99-S102
34. de Alaniz M.J., and Marra C.A. Glucocorticoid and mineralocorticoid hormones depress liver delta 5 desaturase activity through different mechanisms. Lipids 27 (1992) 599-604
35. Mills D.E., Huang Y.S., Narce M., et al. Psychosocial stress, catecholamines, and essential fatty acid metabolism in rats. Proc Soc Exp Biol Med 205 (1994) 56-61
36. Fan Y.Y., and Chapkin R.S. Importance of dietary gamma-linolenic acid in human health and nutrition. J Nutr 128 (1998) 1411-1414
37. Karlstad M.D., DeMichele S.J., Leathem W.D., et al. Effect of intravenous lipid emulsions enriched with gamma-linolenic acid on plasma n-6 fatty acids and prostaglandin biosynthesis after burn and endotoxin injury in rats. Crit Care Med 21 (1993) 1740-1749
38. Johnson M.M., Swan D.D., Surette M.E., et al. Dietary supplementation with gamma-linolenic acid alters fatty acid content and eicosanoid production in healthy humans. J Nutr 127 (1997) 1435-1444
39. Mancuso P., Whelan J., DeMichele S.J., et al. Dietary fish oil and fish and borage oil suppress intrapulmonary proinflammatory eicosanoid biosynthesis and attenuate pulmonary neutrophil accumulation in endotoxic rats. Crit Care Med 25 (1997) 1198-1206
40. Mancuso P., Whelan J., DeMichele S.J., et al. Effects of eicosapentaenoic and gamma-linolenic acid on lung permeability and alveolar macrophage eicosanoid synthesis in endotoxic rats. Crit Care Med 25 (1997) 523-532
41. Murray M.J., Kumar M., Gregory T.J., et al. Select dietary fatty acids attenuate cardiopulmonary dysfunction during acute lung injury in pigs. Am J Physiol 269 (1995) H2090-H2099
42. Murray M.J., Kanazi G., Moukabary K., et al. Effects of eicosapentaenoic and gamma-linolenic acids (dietary lipids) on pulmonary surfactant composition and function during porcine endotoxemia. Chest 117 (2000) 1720-1727
43. Palombo J.D., DeMichele S.J., Lydon E., et al. Cyclic vs continuous enteral feeding with omega-3 and gamma-linolenic fatty acids: effects on modulation of phospholipid fatty acids in rat lung and liver immune cells. J Parenter Enteral Nutr 21 (1997) 123-132
44. Palombo J.D., DeMichele S.J., Boyce P.J., et al. Metabolism of dietary alpha-linolenic acid vs. eicosapentaenoic acid in rat immune cell phospholipids during endotoxemia. Lipids 33 (1998) 1099-1105
45. Palombo J.D., DeMichele S.J., Boyce P.J., et al. Effect of short-term enteral feeding with eicosapentaenoic and gamma-linolenic acids on alveolar macrophage eicosanoid synthesis and bactericidal function in rats. Crit Care Med 27 (1999) 1908-1915
46. Palombo J.D., DeMichele S.J., Lydon E.E., et al. Rapid modulation of lung and liver macrophage phospholipid fatty acids in endotoxemic rats by continuous enteral feeding with n-3 and gamma-linolenic fatty acids. Am J Clin Nutr 63 (1996) 208-219
47. Gadek J.E., DeMichele S.J., Karlstad M.D., et al. Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Enteral Nutrition in ARDS Study Group. Crit Care Med 27 (1999) 1409-1420
48. Pacht E.R., DeMichele S.J., Nelson J.L., et al. Enteral nutrition with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Crit Care Med 31 (2003) 491-500
49. Singer P., Theilla M., Fisher H., et al. Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma-linolenic acid in ventilated patients with acute lung injury. Crit Care Med 34 (2006) 1033-1038
50. Pontes-Arruda A. The effects of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid and antioxidants in patients with sepsis. Crit Care 9 (2005) 363
51. Pontes-Arruda A., Aragao A., and Albuquerque J. The effects of enteral feeding with eicosapentaenoic acid, gamma-linolenic and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Crit Care Med 34 (2006) 2325-2333
52. Elamin E., Hughes L., and Drew D. Effect of enteral nutritional with eicosapentaenoic acid (EPA), gamma-linolenic acid (GLA), and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome (ARDS). Chest 128 (2005) 225S
53. Mayes T., Gottschlich M., Carman B., et al. An evaluation of the safety and efficacy of an anti-inflammatory, pulmonary enteral formula in the treatment of pediatric burn patients with respiratory failure. Nutr Clin Prac 20 (2005) 30-31
54. Carter A.B., Monick M.M., and Hunninghake G.W. Lipopolysaccharide-induced NF-kappaB activation and cytokine release in human alveolar macrophages is PKC-independent and TK- and PC-PLC-dependent. Am J Respir Cell Mol Biol 18 (1998) 384-391
55. Blackwell T.S., Blackwell T.R., Holden E.P., et al. In vivo antioxidant treatment suppresses nuclear factor-kappa B activation and neutrophilic lung inflammation. J Immunol 157 (1996) 1630-1637
56. Schwartz M.D., Moore E.E., Moore F.A., et al. Nuclear factor-kappa B is activated in alveolar macrophages from patients with acute respiratory distress syndrome. Crit Care Med 24 (1996) 1285-1292
57. Kim H.J., Takahashi M., and Ezaki O. Fish oil feeding decreases mature sterol regulatory element-binding protein 1 (SREBP-1) by down-regulation of SREBP-1c mRNA in mouse liver. A possible mechanism for down-regulation of lipogenic enzyme mRNAs. J Biol Chem 274 (1999) 25892-25898
58. Curtis C.L., Hughes C.E., Flannery C.R., et al. n-3 fatty acids specifically modulate catabolic factors involved in articular cartilage degradation. J Biol Chem 275 (2000) 721-724
59. Nadkarni V., DeMichele S., Goldstein B., et al. The nutritional immunomodulation in children with lung injury (NICLI) study group: safety of an enteral formula enriched with eicosapentaenoic and gamma-linolenic acids in critically ill children with acute lung injury. Crit Care Med 12 Suppl (2005) A99